west virginia semaglutide nausea class action Wegovy Lawsuit Ozempic | Simon Law

Peer Reviewed by Rosie Warwick, BSc (Hons) RD Dietitian Rosie is an HCPC-registered clinical dietitian with experience across both paediatric and adult settings

46.FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products

Semaglutide activates GLP-1 receptors in the brain's appetite centers, reducing hunger signals and increasing feelings of fullness

I will tell individuals, patients I'm working with when you keep your weight off, what you want to do is have other people describe you in ways that typify health

Hydration status is frequently overlooked

Lilly's oral GLP-1 drug, Foundayo (orforglipron), recently received FDA approval for obesity in adults and launched in April 2026